CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
57.54
22-十一月-24 16:44:58
15 分钟延时
股票
+1.62
+2.90%
今日范围
56.14 - 57.71
ISIN
N/A
来源
NASDAQ
-
22 7月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
24 6月 2024 16:15:00 条件 Nasdaq GlobeNewswire
-
NetDania - New 12 months High: CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
06 6月 2024 09:45:18 条件 NetDania Notify
-
NetDania - New 12 months High: CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
05 6月 2024 13:50:40 条件 NetDania Notify
-
03 6月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
28 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
01 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Corcept Completes Enrollment in Phase 4 CATALYST Trial
29 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
24 4月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
22 4月 2024 09:59:41 条件 NetDania Notify
-
22 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
15 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
08 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
01 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
15 2月 2024 16:07:00 条件 Nasdaq GlobeNewswire
-
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial
15 2月 2024 16:02:00 条件 Nasdaq GlobeNewswire
-
08 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Corcept Appoints Roberto Vieira as President, Oncology
29 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase Program
08 1月 2024 08:00:01 条件 Nasdaq GlobeNewswire
-
Court Finds Corcept Therapeutics’ Patents Not Infringed
02 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire